Literature DB >> 18285563

A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical hindlimb ischemia.

Ayotunde O Dokun1, Sehoon Keum, Surovi Hazarika, Yongjun Li, Gregory M Lamonte, Ferrin Wheeler, Douglas A Marchuk, Brian H Annex.   

Abstract

BACKGROUND: Peripheral arterial disease (PAD) caused by occlusive atherosclerosis of the lower extremity has 2 major clinical manifestations. Critical limb ischemia is characterized by rest pain and/or tissue loss and has a > or = 40% risk of death and major amputation. Intermittent claudication causes pain on walking, has no tissue loss, and has amputation plus mortality rates of 2% to 4% per year. Progression from claudication to limb ischemia is infrequent. Risk factors in most PAD patients overlap. Thus, we hypothesized that genetic variations may be linked to presence or absence of tissue loss in PAD. METHODS AND
RESULTS: Hindlimb ischemia (murine model of PAD) was induced in C57BL/6, BALB/c, C57BL/6 x BALB/c (F1), F1 x BALB/c (N2), A/J, and C57BL/6J-Chr7(A/J)/NaJ chromosome substitution strains. Mice were monitored for perfusion recovery and tissue necrosis. Genome-wide scanning with polymorphic markers across the 19 murine autosomes was performed on the N2 mice. Greater tissue loss and poorer perfusion recovery occurred in BALB/c than in the C57BL/6 strain. Analysis of 105 N2 progeny identified a single quantitative trait locus on chromosome 7 that exhibited significant linkage to both tissue necrosis and extent of perfusion recovery. Using the appropriate chromosome substitution strain, we demonstrate that C57BL/6-derived chromosome 7 is required for tissue preservation.
CONCLUSIONS: We have identified a quantitative trait locus on murine chromosome 7 (LSq-1) that is associated with the absence of tissue loss in a preclinical model of PAD and may be useful in identifying gene(s) that influence PAD in humans.

Entities:  

Mesh:

Year:  2008        PMID: 18285563      PMCID: PMC2881228          DOI: 10.1161/CIRCULATIONAHA.107.736447

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Map Manager QTX, cross-platform software for genetic mapping.

Authors:  K F Manly; R H Cudmore; J M Meer
Journal:  Mamm Genome       Date:  2001-12       Impact factor: 2.957

2.  P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study.

Authors:  Pierre Fontana; Pascale Gaussem; Martine Aiach; Jean-Noël Fiessinger; Joseph Emmerich; Jean-Luc Reny
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

3.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.

Authors:  Robert J Lederman; Farrell O Mendelsohn; R David Anderson; Jorge F Saucedo; Alan N Tenaglia; James B Hermiller; William B Hillegass; Krishna Rocha-Singh; Thomas E Moon; M J Whitehouse; Brian H Annex
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

4.  Natural history of claudication: long-term serial follow-up study of 1244 claudicants.

Authors:  R Aquino; C Johnnides; M Makaroun; J C Whittle; V S Muluk; M E Kelley; S C Muluk
Journal:  J Vasc Surg       Date:  2001-12       Impact factor: 4.268

Review 5.  Peripheral arterial disease.

Authors:  K Ouriel
Journal:  Lancet       Date:  2001-10-13       Impact factor: 79.321

6.  Apo E genotype, diabetes, and peripheral arterial disease in older men: the Honolulu Asia-aging study.

Authors:  H E Resnick; B Rodriguez; R Havlik; L Ferrucci; D Foley; J D Curb; T B Harris
Journal:  Genet Epidemiol       Date:  2000-07       Impact factor: 2.135

7.  Outcome events in patients with claudication: a 15-year study in 2777 patients.

Authors:  S C Muluk; V S Muluk; M E Kelley; J C Whittle; J A Tierney; M W Webster; M S Makaroun
Journal:  J Vasc Surg       Date:  2001-02       Impact factor: 4.268

8.  Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31.

Authors:  Gudmundur Gudmundsson; Stefan E Matthiasson; Haukur Arason; Halldor Johannsson; Freyr Runarsson; Hjördis Bjarnason; Katrin Helgadottir; Steinthora Thorisdottir; Gudrun Ingadottir; Klaus Lindpaintner; Jesus Sainz; Vilmundur Gudnason; Michael L Frigge; Augustine Kong; Jeffrey R Gulcher; Kari Stefansson
Journal:  Am J Hum Genet       Date:  2002-02-06       Impact factor: 11.025

9.  Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.

Authors:  Surovi Hazarika; Ayotunde O Dokun; Yongjun Li; Aleksander S Popel; Christopher D Kontos; Brian H Annex
Journal:  Circ Res       Date:  2007-09-06       Impact factor: 17.367

10.  Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice.

Authors:  Dimitri Scholz; Tibor Ziegelhoeffer; Armin Helisch; Shawn Wagner; Christian Friedrich; Thomas Podzuweit; Wolfgang Schaper
Journal:  J Mol Cell Cardiol       Date:  2002-07       Impact factor: 5.000

View more
  70 in total

Review 1.  Genetics of peripheral artery disease.

Authors:  Nicholas J Leeper; Iftikhar J Kullo; John P Cooke
Journal:  Circulation       Date:  2012-06-26       Impact factor: 29.690

2.  Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia.

Authors:  Lingdan Chen; Emmanuel Okeke; Dawit Ayalew; Danny Wang; Lyeba Shahid; Ayotunde O Dokun
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-21

3.  Inhibition of protein kinase C beta phosphorylation activates nuclear factor-kappa B and improves postischemic recovery in type 1 diabetes.

Authors:  Satyanarayana Alleboina; Thomas Wong; Madhu V Singh; Ayotunde O Dokun
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

Review 4.  Peripheral arterial disease in diabetes: is there a role for genetics?

Authors:  Arabindra B Katwal; Ayotunde O Dokun
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

5.  Loss of interleukin-21 receptor activation in hypoxic endothelial cells impairs perfusion recovery after hindlimb ischemia.

Authors:  Tao Wang; Alexis Cunningham; Ayotunde O Dokun; Surovi Hazarika; Kevin Houston; Lingdan Chen; R John Lye; Rosanne Spolski; Warren J Leonard; Brian H Annex
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

Review 6.  Systems biology of pro-angiogenic therapies targeting the VEGF system.

Authors:  Feilim Mac Gabhann; Amina A Qutub; Brian H Annex; Aleksander S Popel
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

Review 7.  Modulating the vascular response to limb ischemia: angiogenic and cell therapies.

Authors:  John P Cooke; Douglas W Losordo
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

Review 8.  Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.

Authors:  Peggy Robinet; Dianna M Milewicz; Lisa A Cassis; Nicholas J Leeper; Hong S Lu; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-04       Impact factor: 8.311

Review 9.  TOWARDS THE DEVELOPMENT OF NOVEL THERAPEUTICS FOR PERIPHERAL ARTERY DISEASE.

Authors:  Brian H Annex; George A Beller
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

10.  Murine model of hindlimb ischemia.

Authors:  Hiroshi Niiyama; Ngan F Huang; Mark D Rollins; John P Cooke
Journal:  J Vis Exp       Date:  2009-01-21       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.